Mizuho upgraded shares of HealthSouth Corporation (NYSE:HLS) from a neutral rating to a buy rating in a research note published on Thursday, November 2nd, MarketBeat.com reports. Mizuho currently has $55.00 price objective on the stock.
Several other research analysts have also issued reports on the stock. Zacks Investment Research lowered shares of HealthSouth Corporation from a buy rating to a hold rating in a report on Tuesday, October 31st. Robert W. Baird restated a buy rating and set a $55.00 price target on shares of HealthSouth Corporation in a report on Monday, October 9th. Piper Jaffray Companies restated a hold rating and set a $50.00 price target on shares of HealthSouth Corporation in a report on Sunday, September 17th. KeyCorp reaffirmed a hold rating on shares of HealthSouth Corporation in a research report on Thursday, September 7th. Finally, Royal Bank Of Canada reaffirmed a buy rating and set a $55.00 price objective on shares of HealthSouth Corporation in a research report on Wednesday, September 6th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and five have given a buy rating to the company. The company has a consensus rating of Hold and a consensus target price of $51.75.
Shares of HealthSouth Corporation (HLS) traded down $0.07 during midday trading on Thursday, reaching $48.63. 615,900 shares of the company were exchanged, compared to its average volume of 905,838. The company has a market cap of $4,787.74, a price-to-earnings ratio of 17.45, a PEG ratio of 1.79 and a beta of 0.52. HealthSouth Corporation has a 1-year low of $38.24 and a 1-year high of $49.99. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 1.89.
HealthSouth Corporation (NYSE:HLS) last issued its quarterly earnings data on Thursday, October 26th. The company reported $0.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.65 by $0.01. HealthSouth Corporation had a net margin of 6.69% and a return on equity of 22.81%. The business had revenue of $995.60 million during the quarter, compared to analyst estimates of $985.75 million. During the same quarter last year, the business earned $0.65 EPS. The firm’s quarterly revenue was up 7.4% on a year-over-year basis. analysts predict that HealthSouth Corporation will post 2.72 EPS for the current year.
COPYRIGHT VIOLATION WARNING: “Mizuho Upgrades HealthSouth Corporation (NYSE:HLS) to Buy” was originally reported by BBNS and is the sole property of of BBNS. If you are reading this piece on another website, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be accessed at https://baseballnewssource.com/markets/healthsouth-corporation-hls-upgraded-to-buy-at-mizuho/1752020.html.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 16th. Shareholders of record on Tuesday, January 2nd will be paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 2.06%. The ex-dividend date is Friday, December 29th. HealthSouth Corporation’s dividend payout ratio (DPR) is presently 36.36%.
In related news, Director Yvonne M. Curl acquired 1,000 shares of the company’s stock in a transaction on Wednesday, November 1st. The shares were acquired at an average cost of $45.95 per share, for a total transaction of $45,950.00. Following the purchase, the director now owns 64,144 shares in the company, valued at $2,947,416.80. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. 1.60% of the stock is currently owned by company insiders.
Large investors have recently modified their holdings of the business. First Mercantile Trust Co. lifted its stake in HealthSouth Corporation by 18.8% during the 2nd quarter. First Mercantile Trust Co. now owns 2,720 shares of the company’s stock valued at $132,000 after acquiring an additional 430 shares in the last quarter. Acrospire Investment Management LLC raised its stake in shares of HealthSouth Corporation by 64.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 2,800 shares of the company’s stock worth $136,000 after purchasing an additional 1,100 shares during the period. Advisor Group Inc. raised its stake in shares of HealthSouth Corporation by 33.8% during the 2nd quarter. Advisor Group Inc. now owns 3,092 shares of the company’s stock worth $149,000 after purchasing an additional 781 shares during the period. Petrus Trust Company LTA bought a new stake in shares of HealthSouth Corporation during the 2nd quarter worth $210,000. Finally, HL Financial Services LLC bought a new stake in shares of HealthSouth Corporation during the 2nd quarter worth $213,000. Institutional investors and hedge funds own 93.60% of the company’s stock.
HealthSouth Corporation Company Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with our FREE daily email newsletter.